Annexin V (+)/7AAD (+ or −) percentages of the combined treatments (UVC30/CHW09-25 and UVC30/CHW09-50) for oral cancer cells were higher than its individual treatment and untreated control after 24 h treatment, especially for UVC30/CHW09-50. This evidence concerns the gene ANXA5 and lip and oral cavity carcinoma.